Viewing Study NCT01622660


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-01-08 @ 8:13 AM
Study NCT ID: NCT01622660
Status: TERMINATED
Last Update Posted: 2017-08-22
First Post: 2012-06-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: